CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 153 enrolled
Drug / intervention
Vasopressin +1 moredrug
Likely dose
Vasopressin 20 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04501861
NCT04501861Phase 3Completed

Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients: a Comparative-effectiveness Quality Project

The Cleveland Clinic·interventional·Posted Aug 6, 2020·Updated Mar 24, 2025

In Brief

A Phase 3 clinical trial evaluating Vasopressin and Norepinephrine for Cardiac Disease. Completed, enrolled 153 participants across 1 site.

Detailed Summary

The relative increase in the mPAP with the same unit increase in MAP adjusted for baseline, and RV function assessed by GLS, between VP and NE in patients with normal and increased pulmonary artery pressure, who require vasopressor support during cardiac surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Disease
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
202120222023202420252026
First PostedAug 6, 2020
Enrollment StartNov 5, 2020
Primary CompletionAug 22, 2023
Study CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 5.9 years ago

Interventions

Vasopressindrug

Vasopressin (20 IU/100 ml in 5% dextrose) were stored in pre-mixed bags in the operating room, readily available for continuous infusion administration via pre-programed infusion pumps

Norepinephrinedrug

Norepinephrine (4 mg/250ml in 5% dextrose) were stored in pre-mixed bags in the operating room, readily available for continuous infusion administration via pre-programed infusion pumps